Device / Technology News

RSS

New stretchable bioelectronics advance wearable and implantable health monitoring

Wearable and implantable biosensors have the potential to revolutionize health care by diagnosing, monitoring, and even treating a wide range of health conditions.

11 Jun 2026

One Health framework guides sustainable control of global bacterial zoonoses

Announcing a new article publication for Zoonoses journal. Bacterial zoonoses such as brucellosis, salmonellosis, leptospirosis, anthrax, campylobacteriosis, and listeriosis remain major global health threats with substantial economic and social effects.

11 Jun 2026

Stretchable wound zipper controlled by smartphone app accelerates skin healing

Skin is our protective barrier from the outside world, and it is highly susceptible to damage. To prevent infection, restore protective skin cells, and reduce scarring, it is essential to quickly and robustly close a wound.

11 Jun 2026

Digital simulations struggle to teach "tacit learning" in medicine

A new correspondence highlights a critical gap in modern medical education, arguing that digital simulations and virtual reality fail to transmit the hands-on "tacit learning" essential for clinical practice.

11 Jun 2026

Prospective study compares three robotic platforms for colon resection

Since the introduction of the Da Vinci robotic system, robot-assisted colon resection has gained popularity because of its the potential technical advantages.

11 Jun 2026

Researchers isolate intact tumor microRNAs using antibody-conjugated nanowires

A research team in Japan has developed an efficient and minimally invasive cancer detection device that uses high-performance zinc oxide nanowires to selectively capture extracellular vesicles (EVs) from bodily fluids.

11 Jun 2026

Automated self-driving labs accelerate the search for new medicines

The Acceleration Consortium (AC) at the University of Toronto and the Structural Genomics Consortium (SGC) announced today a formalized partnership to help tackle a persistent challenge in biomedicine and early drug discovery: the development of bioactive molecules with drug-like properties, advancing our understanding of human health and disease and jump-starting new drug discovery programs.

10 Jun 2026

New hybrid lens design drastically cuts 3D microscopy costs and complexity

A team led by Raju Tomer, professor of biological sciences at Columbia University, has created a new design for microscopes and microscope lenses that could push 3D tissue imaging beyond state-of-the-art systems while drastically cutting costs and complexity.

10 Jun 2026

Critical Path Institute opens registration for 2026 Global Impact Conference

Critical Path Institute (C-Path) will host its 2026 Global Impact Conference (CGIC) this September at the Washington Marriott at Metro Center in Washington, D.C.

10 Jun 2026

Aggressive healthcare chatbots push away cervical screening patients

Patients booking cervical screening appointments through an AI chatbot respond positively to friendliness and choice-oriented language, but are put off by over-messaging, pushy reminders and blurred human-AI boundaries, according to new research from the University of Surrey.

10 Jun 2026

Real-time 3D ultrasound in augmented reality helps novices perform like experts

Interpreting medical ultrasound images is a difficult task, requiring a technician to look at 2D images and mentally arrange them into a 3D representation of what the tissue looks like.

10 Jun 2026

New AI system classifies brain tumors with unprecedented accuracy

Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections.

10 Jun 2026

Public health messaging still beats AI chatbots for HPV vaccine promotion

The study finds that AI chatbots boost HPV vaccination intent temporarily, but public health resources are crucial for lasting impact on vaccination decisions.

10 Jun 2026

Laverock Therapeutics reports key oncology research milestones

Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage oncology programs for solid tumor indications.

From Laverock Therapeutics 10 Jun 2026

AI digital twins may improve bilingual aphasia rehabilitation

According to the National Aphasia Association, about 2 million U.S. citizens live with aphasia, but only two-thirds of Americans are aware of the condition, which is a communication disorder that often occurs after a stroke.

9 Jun 2026

Machine learning model filters out the biological noise in liquid biopsy samples

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to their patients' tumors.

9 Jun 2026

AI-powered chatbots no better than written public health materials for vaccine promotion

A new Penn-led randomized controlled trial has found that AI-powered chatbots can make vaccine-hesitant parents more likely to say they will immunize their children against human papillomavirus (HPV), but no more than standard written public health materials.

9 Jun 2026

New digital platform treats insomnia and anxiety in seniors

Cognitive behavioral therapies for insomnia (CBT-I) are increasingly being delivered online in order to improve accessibility.

9 Jun 2026

Radiology AI systems flag breast cancer signs six years before diagnosis

Three commercially available radiology AI systems have shown the potential to flag early signs of breast cancer up to 6 years before a diagnosis, according to a study published in Radiology, the flagship journal of the Radiological Society of North America (RSNA).

9 Jun 2026

Deep learning framework improves vascular cognitive impairment diagnosis

Subcortical ischemic vascular disease (SIVD), driven by cerebral small vessel disease, is commonly characterized by white matter hyperintensities and multiple lacunar infarcts, and a substantial proportion of patients gradually develop cognitive decline and progress to subcortical vascular cognitive impairment (SVCI).

9 Jun 2026